Latest news

December 20, 2005

Debiopharm and Dyax Corp. restructure development agreement for Depelestat (EPI-hNE4 or DX-890) in pulmonary disorders

November 3, 2005

Debiopharm and EPFL launch the “Debiopharm Life Sciences Award”

September 20, 2005

The Japanese Cancer Association (JCA) and Debiopharm present the inaugural 2005 JCA-Mauvernay award in Japan

September 15, 2005

Debiovision Inc., a speciality pharmaceutical developer joins the Debio companies

August 16, 2005

Debiopharm and DeveloGen announce partnering of myasthenia gravis program

June 27, 2005

Debiopharm and Neovacs sign License and Equity Agreement for the development fo Neovacs´ anti-TNF-Alpha product

May 11, 2005

Debiopharm announces marketing and supply agreement for Trelstar® in Canada

April 21, 2005

Debiopharm and NanoCarrier form Research Collaboration on a new platinum compound using the Medicelle TM technology

March 30, 2005

Debiopharm S.A. invests in NanoCarrier Mezzanine Funding Round

Stay informed